Risk of symptomatic COVID-19 due to aircraft transmission: a retrospective cohort study of contact-traced flights during England's containment phase.
Aircraft
COVID-19
Contact tracing
Epidemiology
SARS-CoV-2
Transmission
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
09
01
2021
received:
01
12
2020
accepted:
12
01
2021
pubmed:
3
3
2021
medline:
6
5
2021
entrez:
2
3
2021
Statut:
ppublish
Résumé
Knowledge gaps remain regarding SARS-CoV-2 transmission on flights. We conducted a retrospective cohort study to estimate risk of acquiring symptomatic SARS-CoV-2 on aircraft, to inform contact tracing and infection control efforts. We identified co-passengers of infectious passengers on 18 England-bound flights from European cities up to 12/03/2020, using manifests received for contact tracing. Infectious passengers were laboratory-confirmed cases with symptom onset from 7 days before to 2 days after the flight. Possible aircraft-acquired cases were laboratory-confirmed with onset 3-14 days post-flight with no known non-flight exposure. Manifests was merged with the national case management dataset (identifying cases, onset dates, contact tracing status) and the national COVID-19 linelist. Contact tracing notes were reviewed to identify non-flight exposures. We calculated attack rates (ARs) among all co-passengers and within subgroups, including by distance from infectious cases and number of infectious cases on-board. There were 55 infectious passengers and 2313 co-passengers, including 2221 flight-only contacts. Five possible aircraft-acquired cases were identified; ARs of 0.2% (95%CI 0.1-0.5) among all flight-only contacts and 3.8% (95%CI 1.3-10.6) among contact-traced flight-only contacts sat within a two-seat radius. The AR among 92 co-travellers with known non-flight exposure to infectious cases was 13.0% (95%CI 7.6%-21.4%). There were insufficient numbers to assess differences between subgroups. We conclude that risk of symptomatic COVID-19 due to transmission on short to medium-haul flights is low, and recommend prioritising contact-tracing of close contacts and co-travellers where resources are limited. Further research on risk on aircraft is encouraged.
Sections du résumé
BACKGROUND
Knowledge gaps remain regarding SARS-CoV-2 transmission on flights. We conducted a retrospective cohort study to estimate risk of acquiring symptomatic SARS-CoV-2 on aircraft, to inform contact tracing and infection control efforts.
METHODS
We identified co-passengers of infectious passengers on 18 England-bound flights from European cities up to 12/03/2020, using manifests received for contact tracing. Infectious passengers were laboratory-confirmed cases with symptom onset from 7 days before to 2 days after the flight. Possible aircraft-acquired cases were laboratory-confirmed with onset 3-14 days post-flight with no known non-flight exposure. Manifests was merged with the national case management dataset (identifying cases, onset dates, contact tracing status) and the national COVID-19 linelist. Contact tracing notes were reviewed to identify non-flight exposures. We calculated attack rates (ARs) among all co-passengers and within subgroups, including by distance from infectious cases and number of infectious cases on-board.
RESULTS
There were 55 infectious passengers and 2313 co-passengers, including 2221 flight-only contacts. Five possible aircraft-acquired cases were identified; ARs of 0.2% (95%CI 0.1-0.5) among all flight-only contacts and 3.8% (95%CI 1.3-10.6) among contact-traced flight-only contacts sat within a two-seat radius. The AR among 92 co-travellers with known non-flight exposure to infectious cases was 13.0% (95%CI 7.6%-21.4%). There were insufficient numbers to assess differences between subgroups.
CONCLUSION
We conclude that risk of symptomatic COVID-19 due to transmission on short to medium-haul flights is low, and recommend prioritising contact-tracing of close contacts and co-travellers where resources are limited. Further research on risk on aircraft is encouraged.
Identifiants
pubmed: 33650201
doi: 10.1111/irv.12846
pmc: PMC8013760
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
336-344Informations de copyright
© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Références
Influenza Other Respir Viruses. 2021 May;15(3):336-344
pubmed: 33650201
J Med Virol. 2020 Nov;92(11):2543-2550
pubmed: 32470164
Emerg Infect Dis. 2020 Nov;26(11):2713-2716
pubmed: 32946370
Ann Glob Health. 2016 Sep - Oct;82(5):819-823
pubmed: 28283135
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3623-3627
pubmed: 29555754
CMAJ. 2020 Apr 14;192(15):E410
pubmed: 32392504
Travel Med Infect Dis. 2020 May - Jun;35:101643
pubmed: 32247016
Commun Dis Intell (2018). 2020 Jul 2;44:
pubmed: 32615916
Emerg Infect Dis. 2020 Nov;26(11):2617-2624
pubmed: 32946369